Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/MLTX/Revenue

MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Revenue

MOONLAKE IMMUNOTHERAPEUTICS (MLTX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to MLTX

Source: SEC XBRL filings · For reference only · Not investment advice

More MLTX financial trends

MLTX Net incomeMLTX Net marginMLTX Gross profitMLTX Gross marginMLTX Operating incomeMLTX Operating marginMLTX Operating cash flowMLTX Free cash flowMLTX Capital expendituresMLTX Return on equityMLTX Stock buybacksMLTX Dividends paidMLTX Total assetsMLTX Total liabilitiesMLTX Shareholders’ equityMLTX overview →